{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:19:34Z","timestamp":1792639174062,"version":"4.5.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,28]]},"DOI":"10.1182\/bloodadvances.2021004513","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T17:26:30Z","timestamp":1633713990000},"page":"5501-5506","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2324-7159","authenticated-orcid":false,"given":"Juan","family":"L\u00e1zaro-Navarro","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany;"},{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helia Judith","family":"Pimentel-Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany;"},{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3013-5374","authenticated-orcid":false,"given":"Anton","family":"Gauert","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany;"},{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5491-4607","authenticated-orcid":false,"given":"Anja I. H.","family":"Hagemann","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8650-4247","authenticated-orcid":false,"given":"Jassi","family":"Eisenschmid","sequence":"additional","affiliation":[{"name":"Frankfurt Cancer Institute, Frankfurt, Germany;"},{"name":"Department of Medicine, Hematology\/Oncology, Goethe University Hospital Frankfurt, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"G\u00f6kbuget","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;"},{"name":"Department of Medicine, Hematology\/Oncology, Goethe University Hospital Frankfurt, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binje","family":"Vick","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;"},{"name":"Department of Apoptosis in Hematopoietic Stem Cells, Helmholtz Center Munich, German Center for Environmental Health (HMGU), Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1773-7677","authenticated-orcid":false,"given":"Irmela","family":"Jeremias","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;"},{"name":"Department of Apoptosis in Hematopoietic Stem Cells, Helmholtz Center Munich, German Center for Environmental Health (HMGU), Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Seyfried","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00fcder Hinrich","family":"Meyer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8397-1886","authenticated-orcid":false,"given":"Klaus-Michael","family":"Debatin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Richer","sequence":"additional","affiliation":[{"name":"Medical Department II, Hematology\/Oncology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Bultman","sequence":"additional","affiliation":[{"name":"Medical Department II, Hematology\/Oncology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Neumann","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;"},{"name":"Medical Department II, Hematology\/Oncology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"H\u00e4nzelmann","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-5516","authenticated-orcid":false,"given":"Hubert","family":"Serve","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;"},{"name":"Frankfurt Cancer Institute, Frankfurt, Germany;"},{"name":"Department of Medicine, Hematology\/Oncology, Goethe University Hospital Frankfurt, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Astrahantseff","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Rieger","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;"},{"name":"Frankfurt Cancer Institute, Frankfurt, Germany;"},{"name":"Department of Medicine, Hematology\/Oncology, Goethe University Hospital Frankfurt, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1039-2872","authenticated-orcid":false,"given":"Cornelia","family":"Eckert","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany;"},{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia D.","family":"Baldus","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;"},{"name":"Medical Department II, Hematology\/Oncology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1487-9437","authenticated-orcid":false,"given":"Lorenz","family":"Bastian","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany;"},{"name":"Medical Department II, Hematology\/Oncology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"issue":"6","key":"2021121716302511500_B1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrclinonc.2015.38","article-title":"Genomics in acute lymphoblastic leukaemia: insights and treatment implications","volume":"12","author":"Roberts","year":"2015","journal-title":"Nat Rev Clin Oncol."},{"issue":"1","key":"2021121716302511500_B2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood."},{"issue":"9","key":"2021121716302511500_B3","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.3362","article-title":"Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options","volume":"47","author":"Fischer","year":"2015","journal-title":"Nat Genet."},{"issue":"9","key":"2021121716302511500_B4","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1158\/0008-5472.CAN-18-0236","article-title":"Bcl-2 is a therapeutic target for hypodiploid b-lineage acute lymphoblastic leukemia","volume":"79","author":"Diaz-Flores","year":"2019","journal-title":"Cancer Res."},{"issue":"8","key":"2021121716302511500_B5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41419-019-1801-0","article-title":"Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signaling","volume":"10","author":"Seyfried","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"2021121716302511500_B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/leu.2017.301","article-title":"Therapeutic targeting of CK2 in acute and chronic leukemias","volume":"32","author":"Buontempo","year":"2018","journal-title":"Leukemia."},{"issue":"2","key":"2021121716302511500_B7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/leu.2016.209","article-title":"Protein kinase CK2 regulates AKT, NF-\u03baB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia","volume":"31","author":"Quotti Tubi","year":"2017","journal-title":"Leukemia."},{"issue":"15","key":"2021121716302511500_B8","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1182\/blood-2015-06-651505","article-title":"Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia","volume":"126","author":"Song","year":"2015","journal-title":"Blood."},{"key":"2021121716302511500_B9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/bs.apcsb.2020.09.003","article-title":"Protein kinase CK2 inhibition as a pharmacological strategy","volume":"124","author":"Borgo","year":"2021","journal-title":"Adv Protein Chem Struct Biol."},{"issue":"18","key":"2021121716302511500_B10","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","article-title":"Combenefit: an interactive platform for the analysis and visualization of drug combinations","volume":"32","author":"Di Veroli","year":"2016","journal-title":"Bioinformatics."},{"issue":"3","key":"2021121716302511500_B11","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/10428194.2018.1509314","article-title":"Frequent and reliable engraftment of certain adult primary acute lymphoblastic leukemias in mice","volume":"60","author":"Heckl","year":"2019","journal-title":"Leuk Lymphoma."},{"issue":"6","key":"2021121716302511500_B12","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1158\/1078-0432.CCR-12-1511","article-title":"Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K\/AKT, and NF-\u03baB","volume":"19","author":"Bastian","year":"2013","journal-title":"Clin Cancer Res."},{"issue":"4","key":"2021121716302511500_B13","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2007-06-098012","article-title":"BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia","volume":"111","author":"Del Gaizo Moore","year":"2008","journal-title":"Blood."},{"issue":"2","key":"2021121716302511500_B14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ccr.2010.11.014","article-title":"Early relapse in ALL is identified by time to leukemia in NOD\/SCID mice and is characterized by a gene signature involving survival pathways","volume":"19","author":"Meyer","year":"2011","journal-title":"Cancer Cell."},{"key":"2021121716302511500_B15","doi-asserted-by":"crossref","first-page":"27696","DOI":"10.1038\/srep27696","article-title":"Targeting MCL-1\/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia","volume":"6","author":"Lin","year":"2016","journal-title":"Sci Rep."},{"issue":"7","key":"2021121716302511500_B16","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/0008-5472.CAN-14-1849","article-title":"BH3 inhibitor sensitivity and Bcl-2 dependence in primary acute lymphoblastic leukemia cells","volume":"75","author":"Alford","year":"2015","journal-title":"Cancer Res."},{"issue":"9","key":"2021121716302511500_B17","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1182\/blood-2012-06-440230","article-title":"Requirement for antiapoptotic MCL-1 in the survival of BCR-ABL B-lineage acute lymphoblastic leukemia","volume":"122","author":"Koss","year":"2013","journal-title":"Blood."},{"issue":"6","key":"2021121716302511500_B18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.molcel.2006.02.009","article-title":"Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1","volume":"21","author":"Maurer","year":"2006","journal-title":"Mol Cell."},{"issue":"2","key":"2021121716302511500_B19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/leu.2012.180","article-title":"Downregulation of Mcl-1 through GSK-3\u03b2 activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells","volume":"27","author":"Wang","year":"2013","journal-title":"Leukemia."},{"issue":"12","key":"2021121716302511500_B20","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/2159-8290.CD-18-0140","article-title":"A novel MCL1 inhibitor combined with venetoclax rescues venetoclax-resistant acute myelogenous Leukemia","volume":"8","author":"Ramsey","year":"2018","journal-title":"Cancer Discov."},{"issue":"7","key":"2021121716302511500_B21","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3390\/cancers12071883","article-title":"Fast, in vivo model for drug-response prediction in patients with B-cell precursor acute lymphoblastic leukemia","volume":"12","author":"Gauert","year":"2020","journal-title":"Cancers (Basel)."},{"issue":"1","key":"2021121716302511500_B22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41375-018-0201-2","article-title":"The MCL1-specific inhibitor S63845 acts synergistically with venetoclax\/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells","volume":"33","author":"Li","year":"2019","journal-title":"Leukemia."},{"issue":"1","key":"2021121716302511500_B23","doi-asserted-by":"crossref","first-page":"e1593","DOI":"10.1038\/cddis.2014.525","article-title":"MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K\/AKT\/mTOR activation in lymphoid malignancies","volume":"6","author":"Choudhary","year":"2015","journal-title":"Cell Death Dis."},{"issue":"4","key":"2021121716302511500_B24","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1158\/1541-7786.MCR-20-0586","article-title":"The Heme-Regulated Inhibitor Pathway Modulates Susceptibility of Poor Prognosis B-Lineage Acute Leukemia to BH3-Mimetics","volume":"19","author":"Smith","year":"2021","journal-title":"Mol Cancer Res."},{"issue":"12","key":"2021121716302511500_B25","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/bloodadvances.2019001416","article-title":"Cotargeting BCL-2 and MCL-1 in high-risk B-ALL","volume":"4","author":"Moujalled","year":"2020","journal-title":"Blood Adv."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/24\/5501\/1853747\/advancesadv2021004513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/24\/5501\/1853747\/advancesadv2021004513.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T12:47:10Z","timestamp":1639745230000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/24\/5501\/477170\/Inhibiting-casein-kinase-2-sensitizes-acute"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":25,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2021,12,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004513","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,17]]}}}